Krebs Biochemicals & Industries Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

25.47

31.58

34.21

18.74

19.07

Operating profit

-3.52

-8.17

-26.44

-14.31

-16.59

Interest

2.23

1.05

2.10

3.29

3.36

Gross profit

-5.54

-8.81

-20.79

-17.44

-10.64

EPS (Rs)

-4.13

-5.66

-11.25

-9.40

-6.68

Other income

0.21

0.40

7.76

0.16

9.31

Stock adjustment

-0.18

4.57

-2.66

-2.88

-4.83

Raw material

2.59

11.95

32.41

13.77

17.03

Power and fuel

-

-

-

-

-

Employee expenses

8.15

7.43

8.63

6.67

7.93

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

18.42

15.82

22.27

15.49

15.53

Provisions made

-

-

-

-

-

Depreciation

3.36

3.39

3.46

2.83

2.47

Taxation

-

-

-

-

-

Net profit / loss

-8.90

-12.20

-24.25

-20.27

-13.11

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

21.56

21.56

21.56

21.56

19.62

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-13.82

-25.87

-77.31

-76.40

-87.01

GPM (%)

-21.57

-27.55

-49.55

-92.29

-37.48

NPM (%)

-34.67

-38.13

-57.80

-107.27

-46.19